Keyphrases
2vHPV Vaccine
11%
Adjusted Dose
11%
Age-specific Incidence
22%
Anogenital Warts
100%
Confidence Interval
44%
Dutch
100%
Early Adolescence
11%
Full Vaccination
11%
Fully Vaccinated
11%
General Practice
11%
High-risk Human Papillomavirus (HR-HPV)
11%
HPV Vaccine
11%
HPV-16/18
11%
HPV16
100%
HPV6
11%
Immunization Registry
11%
Incidence Rate
55%
Large Cohort
100%
Large Cohort Study
11%
National Immunization Program
11%
Netherlands
11%
Observation Time
11%
Open Cohort Study
11%
Poisson Regression
11%
Primary Care Data
11%
Primary Care Patients
100%
Protective Effect
100%
Registry-based
11%
Time-dependent Exposure
11%
Vaccination
100%
Vaccination Status
22%
Vaccine Target
11%
INIS
data
50%
doses
75%
humans
100%
information
25%
levels
25%
netherlands
25%
patients
100%
populations
25%
time dependence
25%
vaccines
25%
women
100%
Medicine and Dentistry
Cohort Analysis
11%
General Medicine
11%
Genital Wart
100%
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 6
11%
Immunization Registry
11%
Primary Health Care
100%
Wart Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
10%
Condyloma acuminatum
100%
Human Papillomavirus
10%
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 6
10%
Vaccination Policy
100%
Immunology and Microbiology
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 6
10%
Vaccination Policy
100%
Vaccine Efficacy
10%
Wart Virus
10%